The First Metric Every Investor Must Check Before Buying

When analyzing a stock for the first time, retail investors often get blinded by stock price charts, flashy marketing, or news headlines. But if you want to know whether a business is actually compounding value, you have to look at the top line: Revenue Growth. In this episode, Stephen and Andrew break down the fundamental starting point for analyzing any stock, why top-line growth drives long-term earnings per share (EPS), and how to use base rates to spot unrealistic hypergrowth traps before they wreck your portfolio.

What You Will Learn

The Revenue-to-Price Pipeline: Why McKinsey and Peter Lynch studies prove that revenue growth is the ultimate driver of long-term stock returns.

EPS vs. Stock Price: Why a $20 stock can actually be significantly more expensive than a $500 stock.

The Limit of Cost Cutting: Why companies cannot cost-cut their way to compounding returns—and why profit margins hit a hard ceiling.

The Skewed Data Trap: How single-year anomalies, cyclical spikes, and M&A activity ruin 3- and 5-year screener averages.

The 4%–6% Base Rate Baseline: Michael Mauboussin’s research on real-world corporate growth rates and why expecting 20%+ annual growth forever is a mathematical delusion.

Timestamps

00:00:00 — The Fundamental Starting Point: Why top-line revenue growth is step #1 for stock analysis

00:00:45 — EPS vs. Stock Price: Dissecting valuation so you don't confuse share price with company value

00:04:47 — Revenue Growth vs. Cost Cutting: The mathematical limit of profit margins

00:07:50 — Percentages Over Headline Dollars: Evaluating small caps vs. mega-caps objectively